HSPA13
gene geneOn this page
Summary
HSPA13 (heat shock protein family A (Hsp70) member 13, HGNC:11375) is a protein-coding gene on chromosome 21q11.2, encoding Heat shock 70 kDa protein 13 (P48723). Has peptide-independent ATPase activity. It is a selective cancer dependency (DepMap: 12.7% of cell lines).
The protein encoded by this gene is a member of the heat shock protein 70 family and is found associated with microsomes. Members of this protein family play a role in the processing of cytosolic and secretory proteins, as well as in the removal of denatured or incorrectly-folded proteins. The encoded protein contains an ATPase domain and has been shown to associate with a ubiquitin-like protein.
Source: NCBI Gene 6782 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 68 total — 1 pathogenic
- Cancer dependency (DepMap): dependent in 12.7% of screened cell lines
- MANE Select transcript:
NM_006948
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11375 |
| Approved symbol | HSPA13 |
| Name | heat shock protein family A (Hsp70) member 13 |
| Location | 21q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000155304 |
| Ensembl biotype | protein_coding |
| OMIM | 601100 |
| Entrez | 6782 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000285667, ENST00000478035, ENST00000903931, ENST00000903932
RefSeq mRNA: 1 — MANE Select: NM_006948
NM_006948
CCDS: CCDS13567
Canonical transcript exons
ENST00000285667 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001020226 | 14383095 | 14383146 |
| ENSE00001020231 | 14378199 | 14378412 |
| ENSE00001280391 | 14371115 | 14374284 |
| ENSE00003578743 | 14375652 | 14375819 |
| ENSE00003608679 | 14381203 | 14381543 |
Expression profiles
Bgee: expression breadth ubiquitous, 294 present calls, max score 97.14.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 37.2381 / max 709.2069, expressed in 1806 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 189758 | 37.1410 | 1806 |
| 189759 | 0.0499 | 8 |
| 189760 | 0.0472 | 15 |
Top tissues by expression
299 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ventricular zone | UBERON:0003053 | 97.14 | gold quality |
| cartilage tissue | UBERON:0002418 | 96.58 | gold quality |
| cortical plate | UBERON:0005343 | 96.50 | gold quality |
| islet of Langerhans | UBERON:0000006 | 95.87 | gold quality |
| ganglionic eminence | UBERON:0004023 | 95.80 | gold quality |
| adrenal tissue | UBERON:0018303 | 95.31 | gold quality |
| endothelial cell | CL:0000115 | 95.06 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 94.44 | gold quality |
| corpus epididymis | UBERON:0004359 | 94.44 | gold quality |
| retina | UBERON:0000966 | 94.41 | gold quality |
| type B pancreatic cell | CL:0000169 | 93.82 | gold quality |
| embryo | UBERON:0000922 | 93.65 | gold quality |
| caput epididymis | UBERON:0004358 | 93.54 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 93.07 | gold quality |
| cauda epididymis | UBERON:0004360 | 92.85 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 92.59 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 92.55 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 92.14 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 92.06 | gold quality |
| seminal vesicle | UBERON:0000998 | 91.69 | gold quality |
| postcentral gyrus | UBERON:0002581 | 91.68 | gold quality |
| superficial temporal artery | UBERON:0001614 | 91.66 | gold quality |
| entorhinal cortex | UBERON:0002728 | 91.60 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 91.58 | gold quality |
| medial globus pallidus | UBERON:0002477 | 91.49 | gold quality |
| stromal cell of endometrium | CL:0002255 | 90.97 | gold quality |
| parietal lobe | UBERON:0001872 | 90.79 | gold quality |
| globus pallidus | UBERON:0001875 | 90.78 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 90.78 | gold quality |
| heart right ventricle | UBERON:0002080 | 90.71 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 16.58 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
133 targeting HSPA13, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 12.7% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 7)
- in the Japanese population, STCH might be a new candidate for conferring susceptibility to gastric cancer (PMID:16087163)
- These results suggest that STCH has a role in cell survival via modulation of the TRAIL-mediated cell death pathway. (PMID:18793616)
- An entirely novel path is revealed toward therapeutic intervention of tauopathies by inhibition of the previously untargeted ATPase activity of Hsp70. (PMID:19793966)
- novel role of STCH in the regulation of pHi through site-specific interactions with NBCe1-B and NHE1 and subsequent modulation of membrane transporter expression. (PMID:23303189)
- Hspa13 Promotes Plasma Cell Production and Antibody Secretion. (PMID:32547538)
- Differential Effects of STCH and Stress-Inducible Hsp70 on the Stability and Maturation of NKCC2. (PMID:33672238)
- Heat shock protein Hspa13 regulates endoplasmic reticulum and cytosolic proteostasis through modulation of protein translocation. (PMID:36244454)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | hspa13 | ENSDARG00000040984 |
| mus_musculus | Hspa13 | ENSMUSG00000032932 |
| rattus_norvegicus | Hspa13 | ENSRNOG00000060979 |
| caenorhabditis_elegans | WBGENE00006059 |
Paralogs (13): HSPA5 (ENSG00000044574), HSPA8 (ENSG00000109971), HSPA9 (ENSG00000113013), HSPH1 (ENSG00000120694), HSPA2 (ENSG00000126803), HYOU1 (ENSG00000149428), HSPA4L (ENSG00000164070), HSPA4 (ENSG00000170606), HSPA6 (ENSG00000173110), HSPA14 (ENSG00000187522), HSPA1B (ENSG00000204388), HSPA1A (ENSG00000204389), HSPA1L (ENSG00000204390)
Protein
Protein identifiers
Heat shock 70 kDa protein 13 — P48723 (reviewed: P48723)
Alternative names: Heat shock protein family A member 13, Microsomal stress-70 protein ATPase core, Stress-70 protein chaperone microsome-associated 60 kDa protein
All UniProt accessions (2): P48723, A0A140VK72
UniProt curated annotations — full annotation on UniProt →
Function. Has peptide-independent ATPase activity.
Subunit / interactions. Binds UBQLN2.
Subcellular location. Microsome. Endoplasmic reticulum.
Tissue specificity. Constitutively expressed in all tissues.
Similarity. Belongs to the heat shock protein 70 family.
RefSeq proteins (1): NP_008879* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013126 | Hsp_70_fam | Family |
| IPR018181 | Heat_shock_70_CS | Conserved_site |
| IPR042048 | HSPA13 | Family |
| IPR043129 | ATPase_NBD | Homologous_superfamily |
Pfam: PF00012
UniProt features (5 total): signal peptide 1, chain 1, region of interest 1, compositionally biased region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P48723-F1 | 87.43 | 0.69 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-3371453 | Regulation of HSF1-mediated heat shock response |
MSigDB gene sets: 191 (showing top):
RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, MORF_MSH3, BROWNE_HCMV_INFECTION_8HR_UP, MORF_BRCA1, CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN, LANG_MYB_FAMILY_TARGETS, WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2, RIZKI_TUMOR_INVASIVENESS_3D_DN, MODULE_66, GOBP_PROTEIN_MATURATION, AAACCAC_MIR140, GOBP_PROTEIN_FOLDING, SCHLOSSER_SERUM_RESPONSE_DN, MORF_RAP1A
GO Biological Process (2): protein refolding (GO:0042026), protein folding (GO:0006457)
GO Molecular Function (7): ATP binding (GO:0005524), ATP hydrolysis activity (GO:0016887), heat shock protein binding (GO:0031072), protein folding chaperone (GO:0044183), ATP-dependent protein folding chaperone (GO:0140662), nucleotide binding (GO:0000166), protein binding (GO:0005515)
GO Cellular Component (7): nucleus (GO:0005634), cytoplasm (GO:0005737), endoplasmic reticulum (GO:0005783), cytosol (GO:0005829), plasma membrane (GO:0005886), intracellular membrane-bounded organelle (GO:0043231), extracellular exosome (GO:0070062)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Cellular response to heat stress | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein folding | 2 |
| ATP-dependent activity | 2 |
| intracellular membrane-bounded organelle | 2 |
| intracellular anatomical structure | 2 |
| cellular anatomical structure | 2 |
| cytoplasm | 2 |
| cellular process | 1 |
| protein maturation | 1 |
| adenyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| protein binding | 1 |
| molecular_function | 1 |
| protein folding chaperone | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| binding | 1 |
| endomembrane system | 1 |
| membrane | 1 |
| cell periphery | 1 |
| membrane-bounded organelle | 1 |
| intracellular organelle | 1 |
| extracellular vesicle | 1 |
Protein interactions and networks
STRING
3845 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HSPA13 | UBQLN2 | Q9UHD9 | 984 |
| HSPA13 | UBQLN4 | Q9NRR5 | 827 |
| HSPA13 | UBQLN1 | Q9UMX0 | 812 |
| HSPA13 | LIPI | Q6XZB0 | 750 |
| HSPA13 | HSPA12A | O43301 | 744 |
| HSPA13 | B0YIZ1 | B0YIZ1 | 695 |
| HSPA13 | HSPA12B | Q96MM6 | 690 |
| HSPA13 | STIP1 | P31948 | 674 |
| HSPA13 | PLEKHG4 | Q58EX7 | 547 |
| HSPA13 | QKI | Q96PU8 | 542 |
| HSPA13 | RBPMS | Q93062 | 515 |
| HSPA13 | RBM17 | Q96I25 | 511 |
| HSPA13 | PQBP1 | O60828 | 510 |
| HSPA13 | HSP90B1 | P14625 | 503 |
| HSPA13 | ATXN1 | P54253 | 497 |
IntAct
140 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HSPA13 | UBQLN1 | psi-mi:“MI:0915”(physical association) | 0.830 |
| UBQLN1 | HSPA13 | psi-mi:“MI:0915”(physical association) | 0.830 |
| SGTA | HSPA13 | psi-mi:“MI:0915”(physical association) | 0.720 |
| HSPA13 | SGTA | psi-mi:“MI:0915”(physical association) | 0.720 |
| HSPA13 | UBQLN1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| HSPA13 | SGTB | psi-mi:“MI:0915”(physical association) | 0.670 |
| HSPA13 | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| FBXO6 | MAN2B1 | psi-mi:“MI:0914”(association) | 0.640 |
| DKKL1 | DENND11 | psi-mi:“MI:0914”(association) | 0.640 |
| HSPA13 | B4GALT5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSPA13 | CRYGA | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRSS22 | PPM1A | psi-mi:“MI:0914”(association) | 0.560 |
| HSPA13 | POLE4 | psi-mi:“MI:0915”(physical association) | 0.550 |
| TNF | B4GALT5 | psi-mi:“MI:0914”(association) | 0.530 |
| TOR1AIP1 | TXN | psi-mi:“MI:0914”(association) | 0.530 |
| CMA1 | MANBA | psi-mi:“MI:0914”(association) | 0.530 |
| FBXO2 | TMEM131L | psi-mi:“MI:0914”(association) | 0.530 |
| HSPA13 | BAG6 | psi-mi:“MI:0915”(physical association) | 0.370 |
| HSPA13 | RMI1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| HSPA13 | SSR1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TANK | CNOT1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (154): HSPA13 (Two-hybrid), UBQLN1 (Two-hybrid), HSPA13 (Affinity Capture-MS), HSPA13 (Affinity Capture-MS), HSPA13 (Affinity Capture-MS), UBQLN1 (Two-hybrid), HSPA13 (Two-hybrid), HSPA13 (Affinity Capture-MS), HSPA13 (Affinity Capture-MS), B4GALT5 (Affinity Capture-MS), HSPA13 (Affinity Capture-MS), HSPA13 (Proximity Label-MS), HSPA13 (Affinity Capture-MS), HSPA13 (Affinity Capture-MS), HSPA13 (Affinity Capture-MS)
ESM2 similar proteins: A1AWL7, A3M561, A8GMI8, A8GR49, B0BWJ7, B0VD55, B0VNV8, B2HZI1, B7H3H4, B7I5P9, C3PMP2, C4K0Z7, D1J722, D4A2Z8, E9PU17, E9PX95, F4IM84, G7LCC3, O35162, O52960, O88967, O96566, P48723, P52914, P70106, P80595, P99502, Q05931, Q18411, Q1RJ70, Q2TBX4, Q3UW68, Q4UKL3, Q4V339, Q55154, Q5E780, Q5JTY5, Q5R8D9, Q5RIA9, Q5XI69
Diamond homologs: A0A509AJG0, A2Q0Z1, A5A8V7, F5HB71, G0SCU5, G3I8R9, J9VZ70, O35162, O59855, O73885, O97125, P02827, P06761, P07823, P08108, P08418, P09435, P0DMV8, P0DMV9, P0DMW0, P0DMW1, P10591, P10592, P11021, P11142, P11147, P14659, P17066, P17156, P17879, P19120, P19208, P19378, P20029, P20163, P22202, P27420, P29843, P29844, P34930
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 131 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 5 | 24.8× | 7e-04 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| ERAD pathway | 11 | 16.1× | 9e-08 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
68 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 55 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 625662 | GRCh37/hg19 21p11.1-q21.2(chr21:10944001-25730963) | Pathogenic |
SpliceAI
654 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 21:14375646:TCTTA:T | donor_loss | 1.0000 |
| 21:14375647:CTTA:C | donor_loss | 1.0000 |
| 21:14375648:TTACC:T | donor_loss | 1.0000 |
| 21:14375649:TACCA:T | donor_loss | 1.0000 |
| 21:14375650:A:AC | donor_gain | 1.0000 |
| 21:14375650:A:T | donor_loss | 1.0000 |
| 21:14375651:C:CC | donor_gain | 1.0000 |
| 21:14375651:CCAGA:C | donor_gain | 1.0000 |
| 21:14375677:C:A | donor_gain | 1.0000 |
| 21:14375680:T:TA | donor_gain | 1.0000 |
| 21:14375729:A:AC | donor_gain | 1.0000 |
| 21:14375815:CAGTC:C | acceptor_gain | 1.0000 |
| 21:14375817:GTC:G | acceptor_gain | 1.0000 |
| 21:14375817:GTCC:G | acceptor_loss | 1.0000 |
| 21:14375818:TC:T | acceptor_gain | 1.0000 |
| 21:14375818:TCCT:T | acceptor_loss | 1.0000 |
| 21:14375819:CC:C | acceptor_gain | 1.0000 |
| 21:14375820:C:CC | acceptor_gain | 1.0000 |
| 21:14375828:T:TC | acceptor_gain | 1.0000 |
| 21:14375832:T:C | acceptor_gain | 1.0000 |
| 21:14375832:T:TC | acceptor_gain | 1.0000 |
| 21:14378193:TGTTA:T | donor_loss | 1.0000 |
| 21:14378194:GTTAC:G | donor_loss | 1.0000 |
| 21:14378195:TTA:T | donor_loss | 1.0000 |
| 21:14378196:TAC:T | donor_loss | 1.0000 |
| 21:14378197:A:AT | donor_loss | 1.0000 |
| 21:14378198:C:T | donor_loss | 1.0000 |
| 21:14381199:TTA:T | donor_loss | 1.0000 |
| 21:14381200:TA:T | donor_loss | 1.0000 |
| 21:14381201:A:AC | donor_gain | 1.0000 |
AlphaMissense
3073 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 21:14381270:T:A | K100I | 1.000 |
| 21:14381362:G:C | S69R | 1.000 |
| 21:14381362:G:T | S69R | 1.000 |
| 21:14381364:T:G | S69R | 1.000 |
| 21:14373703:C:G | A444P | 0.999 |
| 21:14373711:G:T | A441D | 0.999 |
| 21:14373712:C:G | A441P | 0.999 |
| 21:14373717:C:T | G439E | 0.999 |
| 21:14373718:C:G | G439R | 0.999 |
| 21:14373718:C:T | G439R | 0.999 |
| 21:14373804:C:G | R410P | 0.999 |
| 21:14373816:C:A | G406V | 0.999 |
| 21:14373816:C:T | G406E | 0.999 |
| 21:14373817:C:A | G406W | 0.999 |
| 21:14373817:C:G | G406R | 0.999 |
| 21:14373817:C:T | G406R | 0.999 |
| 21:14374137:A:G | L299P | 0.999 |
| 21:14374145:T:A | K296N | 0.999 |
| 21:14374145:T:G | K296N | 0.999 |
| 21:14374269:C:A | G255V | 0.999 |
| 21:14374269:C:T | G255E | 0.999 |
| 21:14374270:C:G | G255R | 0.999 |
| 21:14374270:C:T | G255R | 0.999 |
| 21:14375661:C:G | A247P | 0.999 |
| 21:14375693:A:G | L236P | 0.999 |
| 21:14375700:A:G | S234P | 0.999 |
| 21:14375708:A:G | L231P | 0.999 |
| 21:14375725:G:C | D225E | 0.999 |
| 21:14375725:G:T | D225E | 0.999 |
| 21:14375726:T:G | D225A | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000206146 (21:14381057 G>A), RS1000726163 (21:14385113 C>CA), RS1001020582 (21:14373295 T>C), RS1001284093 (21:14379654 T>C), RS1001474415 (21:14372940 T>C), RS1001576630 (21:14374031 G>A), RS1001664002 (21:14380733 G>A), RS1002287917 (21:14378089 T>C), RS1002318712 (21:14374779 G>A), RS1002574135 (21:14385049 G>C), RS1002655197 (21:14378820 A>C,G), RS1002665126 (21:14379116 T>G), RS1002993100 (21:14372511 A>G), RS1003404258 (21:14376926 C>A), RS1003762574 (21:14377104 T>C)
Disease associations
OMIM: gene MIM:601100 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
75 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cyclosporine | increases expression | 4 |
| bisphenol A | affects expression, increases expression, decreases expression | 3 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 3 |
| Air Pollutants | increases expression, decreases expression, increases abundance | 3 |
| Estradiol | increases expression | 3 |
| Tetrachlorodibenzodioxin | decreases expression, affects expression | 3 |
| mono-(2-ethylhexyl)phthalate | decreases expression, decreases methylation, increases abundance | 2 |
| Acetaminophen | increases expression | 2 |
| Arsenic | increases abundance, increases expression, affects expression, affects cotreatment | 2 |
| Nickel | increases expression | 2 |
| Valproic Acid | decreases expression, increases expression | 2 |
| Particulate Matter | decreases expression, increases abundance, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| 2,4,6-tribromophenol | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| glycidyl methacrylate | increases expression | 1 |
| trichostatin A | decreases expression | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| methylparaben | increases expression | 1 |
| sulforaphane | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| cobaltous chloride | increases expression | 1 |
| tetrabromobisphenol A | increases expression | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| tri-o-cresyl phosphate | increases expression | 1 |
| cupric oxide | increases expression | 1 |
| hydroquinone | increases expression | 1 |
| brequinar | increases expression | 1 |
Cellosaurus cell lines
3 cell lines: 3 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D1N9 | Abcam K-562 HSPA13 KO | Cancer cell line | Female |
| CVCL_D2JU | Abcam Raji HSPA13 KO | Cancer cell line | Male |
| CVCL_UQ75 | Abcam Jurkat HSPA13 KO | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.